Traditional Chinese Medicine and Traditional Indonesian Medicine: A Comparative Review of Herbal Medicines Restricted in Pregnancy

Jun, Purumea; Rahmat, Endang; Han, Chang‐Hyun; Yang, Changsop; Kang, Young Min

doi:10.1007/s11655-021-3487-7

Cited by 18 publications

(10 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, if patients use Western medicine with contraindications or strong side effects, Chinese medicine treatment may become an alternative to Western medicine treatment. Chinese medicine is more commonly used in Taiwan to nourish, invigorate, and adjust the body [31,32]. Some women who have experienced infertility, miscarriage, or want to have a smooth pregnancy may also turn to traditional Chinese medicine to recuperate their body.…”

Section: Discussionmentioning

confidence: 99%

The Lived Experience of First-time Mothers with Congenital Heart Disease

Liu

et al. 2022

Asian Nursing Research

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The Lived Experience of First-time Mothers with Congenital Heart Disease

Liu

et al. 2022

Asian Nursing Research

View full text Add to dashboard Cite

“…After the intersection of drug targets and disease targets, a "drug-intersection target gene-disease" network is constructed. The interactions between drugs and diseases are explored through visualization tools and algorithms to reveal the potential mechanisms of drug treatments for diseases [81,82].…”

Section: Network Pharmacologymentioning

confidence: 99%

Multi-component Chinese medicine formulas for drug discovery: State of the art and future perspectives

Zhang

Chen

Tang

et al. 2023

Acta Materia Medica

View full text Add to dashboard Cite

For hundreds of years, the drug discovery and development industry has aimed at identifying single components with a clear mechanism of action as desirable candidates for potential drugs. However, this conventional strategy of drug discovery and development has faced challenges including a low success rate and high development costs. Herein, we critically review state-of-the-art drug discovery and development based on multi-component Chinese medicine formulas. We review the policies and application status of new drugs based on multi-component Chinese medicines in the US, China, and the European Union. Moreover, we illustrate several excellent cases of ongoing applications. Biomedical technologies that may facilitate drug discovery and development based on multi-component Chinese medicine formulas are discussed, including network pharmacology, integrative omics, CRISPR gene editing, and chemometrics. Finally, we discuss potential problems and solutions in pre-clinical and clinical research in drug discovery and development based on multi-component Chinese medicine formulas. We hope that this review will promote discussion of the roles of multi-component Chinese medicine formulas in the discovery and development of new drugs for the treatment of human diseases.

show abstract

“…Rikkunshito contains extracts from eight plants, including Ginseng radix and Pinelliae ternata 161 . Ginseng radix , or ginseng, was shown to have direct teratogenic effects on rat embryos and is not recommended as treatment during pregnancy 162,163 . Pinelliae ternata , or crow‐dipper, was shown in one study to alter the metabolic pathways in placentas and amniotic fluid of pregnant rats with unknown implications 164 …”

Section: Management Of Pre‐existing Functional Dyspepsia In Pregnancymentioning

confidence: 99%

“…161 Ginseng radix, or ginseng, was shown to have direct teratogenic effects on rat embryos and is not recommended as treatment during pregnancy. 162,163 Pinelliae ternata, or crow-dipper, was shown in one study to alter the metabolic pathways in placentas and amniotic fluid of pregnant rats with unknown implications. 164 Cynara cardunculus, or artichoke, extract administration improved overall symptoms and quality of life at 6 weeks compared to placebo in one double-blind RCT of 247 patients with FD.…”

Section: Herbal Therapiesmentioning

confidence: 99%

Review article: Functional dyspepsia and pregnancy—Effects and management in a special population

Liu

Starkey

Virani

et al. 2023

Aliment Pharmacol Ther

View full text Add to dashboard Cite

Background: Around 10% of Americans meet the Rome IV criteria for functional dyspepsia (FD), with a significantly higher rate in women. FD also has a higher prevalence in women below the age of 50, suggesting that women who are affected are likely to be of reproductive age. Unfortunately, there is a lack of research or evidence-based guidelines on managing FD in pregnancy. Aims and Methods:To address this issue, we aimed to perform a systematic review of the interactions between FD and pregnancy and managing pre-existing FD in the peripartum and post-partum phases using current lifestyle, pharmacological, nonpharmacological and alternative medicine interventions. Results: Due to the lack of Rome IV FD-specific data in pregnancy, we instead performed a narrative review on how existing FD interventions could be extrapolated to the pregnant population. Where possible we use the highest level of available evidence or official guidelines to answer these questions, which often involves synthesising treatment and safety evidence of these interventions in other diseases during pregnancy. Finally, we highlight current substantial knowledge gaps requiring further research for the safe management of a pregnant patient with pre-existing FD. Conclusions: Overall, despite the paucity of knowledge of treating FD during pregnancy, providers can mitigate this uncertainty by planning ahead with the patient. Patients should ideally minimise treatment until after breastfeeding. However, interdisciplinary resources are available to ensure that minimal-risk interventions are maximised, while interventions with more risks, if necessary, are justifiable by both the patient and the care team. Future investigations should continue to elicit the mechanistic relationship between FD and pregnancy while cautiously expanding prospective research on promising and safe therapies in pregnant patients with preexisting FD.

show abstract

Traditional Chinese Medicine and Traditional Indonesian Medicine: A Comparative Review of Herbal Medicines Restricted in Pregnancy

Cited by 18 publications

References 40 publications

The Lived Experience of First-time Mothers with Congenital Heart Disease

The Lived Experience of First-time Mothers with Congenital Heart Disease

Multi-component Chinese medicine formulas for drug discovery: State of the art and future perspectives

Review article: Functional dyspepsia and pregnancy—Effects and management in a special population

Contact Info

Product

Resources

About